← Open Payments lookup

DAYTRAL BROWN: Open Payments

NPI 1154629798 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$221 in 10 payments from 7 companies in 2025. Trend: 2023 $164 · 2024 $87 · 2025 $221

Food & beverage: $221
CompanyPaymentsAmount
Novo Nordisk Inc2$69
ABBVIE INC.2$33
AstraZeneca Pharmaceuticals LP2$30
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$24
IDORSIA PHARMACEUTICALS US INC1$24
Janssen Pharmaceuticals, Inc1$24
Lilly USA, LLC1$17

Products named: Ozempic, VRAYLAR, FARXIGA, CAPLYTA, Quviviq, SPRAVATO, MOUNJARO.

Industry payments across TX — which companies pay providers there.